ImmunoGen Message Board - Msg: 32127742

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	4/25/2019 2:05:22 AM
	of 5665

I've taken a small gamble on ASCO. I believe that IMGN by ASCO will reveal a plan of action for the approval of IMGN853. If I'm correct about that, I think the stock will return to a trading range above $5. I've purchased June $4 calls, I'm tying up 5K shares for less than the cost of 200 shares, if I'm right, I'll be able to add a few thousand shares to my portfolio for less than the cost of 200 shares today. I really don't know what path will be taken to approval, the Phase 3 may actually have all that's needed to gain it for a somewhat smaller target. Other possibilities might include approval from one of the Phase 2 Trials, or a trial to supplement the Phase 3 Trial adding more patients who'd see the greater benefit. On the other hand, survival could prove to be all that's needed if the patients in the trial are tracked for an additional 6 months or a year, the survival benefit was clearly there, but would be even more apparent with more time. In short, I believe it's just a matter of time before the drug is approved and I'm hoping the course of action is clear by ASCO. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next